Zane LT[Author] - Search Results

Year	Number of Results
1994	1
2004	1
2005	2
2006	3
2007	2
2008	2
2009	1
2012	1
2014	1
2015	6
2016	11
2017	5
2018	3
2024	0

1

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.

Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, Eichenfield LF, Forsha DW, Rees WC, Simpson EL, Spellman MC, Stein Gold LF, Zaenglein AL, Hughes MH, Zane LT, Hebert AA. Paller AS, et al. Among authors: zane lt. J Am Acad Dermatol. 2016 Sep;75(3):494-503.e6. doi: 10.1016/j.jaad.2016.05.046. Epub 2016 Jul 11. J Am Acad Dermatol. 2016. PMID: 27417017 Free article. Clinical Trial.

2

Dermatologic manifestations of polycystic ovary syndrome.

Lee AT, Zane LT. Lee AT, et al. Among authors: zane lt. Am J Clin Dermatol. 2007;8(4):201-19. doi: 10.2165/00128071-200708040-00003. Am J Clin Dermatol. 2007. PMID: 17645376 Review.

3

Antifungal agents for onychomycosis: new treatment strategies to improve safety.

Zane LT, Chanda S, Coronado D, Del Rosso J. Zane LT, et al. Dermatol Online J. 2016 Mar 16;22(3):13030/qt8dg124gs. Dermatol Online J. 2016. PMID: 27136621 Free article. Review.

4

Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies.

Zane LT, Chanda S, Jarnagin K, Nelson DB, Spelman L, Gold LS. Zane LT, et al. Immunotherapy. 2016 Jul;8(8):853-66. doi: 10.2217/imt-2016-0023. Epub 2016 Jun 10. Immunotherapy. 2016. PMID: 27283509 Free article. Review.

5

Recent advances in acne vulgaris research: insights and clinical implications.

Wang KC, Zane LT. Wang KC, et al. Among authors: zane lt. Adv Dermatol. 2008;24:197-209. doi: 10.1016/j.yadr.2008.09.002. Adv Dermatol. 2008. PMID: 19256310 Review.

6

Tavaborole topical solution, 5% for the treatment of toenail onychomycosis.

Zane LT, Plattner J, Chanda S, Coronado D, Merchant T, Alley MR, Gupta AK. Zane LT, et al. Drugs Today (Barc). 2015 Oct;51(10):599-607. doi: 10.1358/dot.2015.51.10.2401004. Drugs Today (Barc). 2015. PMID: 26583302 Review.

7

Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic Dermatitis.

Jarnagin K, Chanda S, Coronado D, Ciaravino V, Zane LT, Guttman-Yassky E, Lebwohl MG. Jarnagin K, et al. Among authors: zane lt. J Drugs Dermatol. 2016 Apr;15(4):390-6. J Drugs Dermatol. 2016. PMID: 27050693 Review.

8

Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review.

Marqueling AL, Zane LT. Marqueling AL, et al. Among authors: zane lt. Semin Cutan Med Surg. 2005 Jun;24(2):92-102. doi: 10.1016/j.sder.2005.04.003. Semin Cutan Med Surg. 2005. PMID: 16092797 Review.

9

Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review.

Marqueling AL, Zane LT. Marqueling AL, et al. Among authors: zane lt. Semin Cutan Med Surg. 2007 Dec;26(4):210-20. doi: 10.1016/j.sder.2008.03.005. Semin Cutan Med Surg. 2007. PMID: 18395669 Review.

10

Acne maintenance therapy: expanding the role of topical retinoids?

Zane LT. Zane LT. Arch Dermatol. 2006 May;142(5):638-40. doi: 10.1001/archderm.142.5.638. Arch Dermatol. 2006. PMID: 16702503 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year